1. Home
  2. MWA vs ERAS Comparison

MWA vs ERAS Comparison

Compare MWA & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MUELLER WATER PRODUCTS

MWA

MUELLER WATER PRODUCTS

HOLD

Current Price

$25.09

Market Cap

3.9B

Sector

Industrials

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$19.29

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MWA
ERAS
Founded
1857
2018
Country
United States
United States
Employees
3500
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
MWA
ERAS
Price
$25.09
$19.29
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$30.50
$14.25
AVG Volume (30 Days)
1.2M
5.6M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
1.01%
N/A
EPS Growth
64.86
36.23
EPS
0.65
N/A
Revenue
$1,429,700,000.00
N/A
Revenue This Year
$4.78
N/A
Revenue Next Year
$4.27
N/A
P/E Ratio
$38.28
N/A
Revenue Growth
8.75
N/A
52 Week Low
$22.74
$1.33
52 Week High
$31.00
$24.28

Technical Indicators

Market Signals
Indicator
MWA
ERAS
Relative Strength Index (RSI) 46.91 59.23
Support Level $24.81 $17.63
Resistance Level $26.05 $21.60
Average True Range (ATR) 0.58 1.29
MACD 0.01 -0.16
Stochastic Oscillator 35.98 41.03

Price Performance

Historical Comparison
MWA
ERAS

About MWA MUELLER WATER PRODUCTS

Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: